Brady Todd C
Insider CIK 1579179 · ALDX President and CEO, Director · EVOK Director · SBPH Director · ONS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2026-06-03 | 2026-06-05 | 250,000 | $1.67 | $417.5K | 1,721,298 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-03-27 | 2026-03-31 | 632,318 | — | $0 | 632,318 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-03-27 | 2026-03-31 | 1,880,510 | — | $0 | 1,880,510 | SEC↗ |
| EVOK Evoke Pharma Inc | D To issuer deriv | 2025-12-17 | 2025-12-17 | 1,187 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | D To issuer deriv | 2025-12-17 | 2025-12-17 | 1,218 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | D To issuer deriv | 2025-12-17 | 2025-12-17 | 5,833 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | U Tender | 2025-12-16 | 2025-12-17 | 27 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2025-05-21 | 2025-05-22 | 1,187 | — | $0 | 8,238 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2025-03-04 | 2025-03-06 | 809,710 | — | $0 | 809,710 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2025-01-28 | 2025-01-29 | 5,833 | — | $0 | 5,833 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2024-05-22 | 2024-05-24 | 14,625 | — | $0 | 14,625 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-12 | 85,324 | $3.05 | $260.2K | 1,471,298 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-12 | 97,914 | $3.27 | $320.2K | 1,556,622 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2024-03-09 | 2024-03-12 | 1,081,201 | — | $0 | 1,081,201 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2023-09-07 | 2023-09-11 | 32,953 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2023-09-07 | 2023-09-11 | 192,084 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2023-09-07 | 2023-09-11 | 48,021 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2023-09-07 | 2023-09-11 | 32,953 | $0.55 | $18.1K | 1,680,322 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2023-09-07 | 2023-09-11 | 48,021 | $0.55 | $26.4K | 1,728,343 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2023-09-07 | 2023-09-11 | 73,807 | $7.22 | $532.9K | 1,654,536 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2023-09-07 | 2023-09-11 | 192,084 | $0.55 | $105.6K | 1,647,369 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2023-05-10 | 2023-05-11 | 14,625 | — | $0 | 14,625 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | U Tender | 2023-03-08 | 2023-03-09 | 15,004 | $7.12 | $106.8K | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2023-02-28 | 2023-03-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award | 2023-02-28 | 2023-03-02 | 238,750 | — | $0 | 1,455,285 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-07-15 | 2022-07-19 | 604,308 | — | $0 | 604,308 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2022-06-23 | 2022-06-27 | 17,700 | $3.36 | $59.5K | 1,216,535 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2022-04-27 | 2022-04-28 | 57,750 | — | $0 | 57,750 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-03-30 | 2022-04-01 | 207,758 | — | $0 | 207,758 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-03-30 | 2022-04-01 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award | 2022-03-30 | 2022-04-01 | 250,000 | — | $0 | 1,198,835 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | A Award deriv | 2021-06-04 | 2021-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2021-05-05 | 2021-07-23 | 57,750 | — | $0 | 57,750 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2021-04-12 | 2021-04-14 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award | 2021-04-12 | 2021-04-14 | 46,619 | — | $0 | 948,835 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | J Other deriv | 2020-11-20 | 2023-03-09 | 11,000 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | J Other deriv | 2020-11-20 | 2023-03-09 | 10,964 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | J Other deriv | 2020-11-20 | 2023-03-09 | 5,500 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | J Other deriv | 2020-11-20 | 2023-03-09 | 5,500 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | J Other deriv | 2020-11-20 | 2023-03-09 | 7,500 | — | $0 | 0 | SEC↗ |
| FSTX F-star Therapeutics, Inc. | J Other deriv | 2020-11-20 | 2023-03-09 | 7,500 | — | $0 | 0 | SEC↗ |
| SBPH F-star Therapeutics, Inc. | J Other deriv | 2020-11-19 | 2020-11-23 | 2,741 | — | $0 | 0 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2020-09-30 | 2020-10-01 | 9,235 | — | $0 | 60,016 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2020-06-30 | 2020-07-01 | 8,418 | — | $0 | 50,781 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award deriv | 2020-06-24 | 2020-06-25 | 7,500 | — | $0 | 7,500 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2020-05-27 | 2020-05-29 | 57,750 | — | $0 | 57,750 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2020-03-31 | 2020-04-01 | 13,306 | — | $0 | 42,363 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 450,865 | — | $0 | 450,865 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award | 2020-03-02 | 2020-03-04 | 250,000 | — | $0 | 902,216 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2019-12-31 | 2020-01-02 | 7,832 | — | $0 | 29,057 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-12-16 | 2019-12-18 | 20,000 | $5.10 | $102.0K | 652,216 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2019-09-30 | 2019-10-01 | 3,597 | — | $0 | 21,225 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-30 | 2019-10-02 | 8,710 | $5.68 | $49.5K | 632,216 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-23 | 2019-09-25 | 8,680 | $5.81 | $50.4K | 623,506 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-18 | 2019-09-20 | 14,288 | $5.91 | $84.4K | 614,826 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-16 | 2019-09-17 | 3,000 | $6.03 | $18.1K | 591,991 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-16 | 2019-09-17 | 3,000 | $6.03 | $18.1K | 600,538 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-13 | 2019-09-17 | 10,000 | $5.79 | $57.9K | 588,991 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-13 | 2019-09-17 | 18,547 | $5.90 | $109.4K | 597,538 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-10 | 2019-09-11 | 10,000 | $5.39 | $53.9K | 578,991 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-09 | 2019-09-11 | 10,000 | $4.89 | $48.9K | 568,991 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award deriv | 2019-07-10 | 2019-07-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2019-06-28 | 2019-07-01 | 3,354 | — | $0 | 17,628 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2019-05-02 | 2019-05-03 | 34,000 | — | $0 | 34,000 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2019-03-29 | 2019-04-02 | 1,180 | — | $0 | 14,274 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2019-03-05 | 2019-03-07 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2019-03-05 | 2019-03-07 | 45,329 | — | $0 | 45,329 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award | 2019-03-05 | 2019-03-07 | 250,000 | — | $0 | 556,054 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award deriv | 2018-06-18 | 2018-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2018-04-26 | 2018-04-27 | 34,000 | — | $0 | 34,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2018-03-06 | 2018-03-08 | 217,293 | — | $0 | 217,293 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award | 2018-03-06 | 2018-03-08 | 101,269 | — | $0 | 302,483 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2018-01-02 | 2018-01-03 | 852 | — | $0 | 13,094 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2017-10-26 | 2017-10-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2017-10-02 | 2017-10-03 | 633 | — | $0 | 12,242 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2017-07-03 | 2017-07-05 | 645 | — | $0 | 11,609 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award deriv | 2017-06-15 | 2017-06-16 | 5,500 | — | $0 | 5,500 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2017-05-03 | 2017-05-05 | 34,000 | — | $0 | 34,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2017-03-03 | 2017-03-07 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award | 2017-03-03 | 2017-03-07 | 136,806 | — | $0 | 201,214 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2017-02-17 | 2017-02-21 | 22,223 | $4.50 | $100.0K | 64,408 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award deriv | 2016-11-23 | 2016-11-23 | 10,964 | — | $0 | 10,964 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award | 2016-11-23 | 2016-11-23 | 10,964 | $9.12 | $100.0K | 10,964 | SEC↗ |
| ONS Oncobiologics, Inc. | M Exercise | 2016-11-09 | 2016-11-14 | 28,985 | — | $0 | 153,288 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion | 2016-11-09 | 2016-11-14 | 28,985 | — | $0 | 28,985 | SEC↗ |
| SBPH Spring Bank Pharmaceutical | A Award deriv | 2016-07-28 | 2016-07-29 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion deriv | 2016-05-18 | 2016-05-18 | 398 | — | $0 | 0 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion | 2016-05-18 | 2016-05-18 | 66,333 | — | $0 | 124,303 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award | 2016-05-03 | 2016-05-05 | 27,096 | — | $0 | 42,185 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2016-04-27 | 2016-04-29 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2016-03-16 | 2016-05-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2016-03-16 | 2016-03-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2015-06-03 | 2015-06-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2015-04-22 | 2015-04-24 | 9,000 | — | $0 | 9,000 | SEC↗ |
| EVOK Evoke Pharma Inc | P Buy | 2014-09-23 | 2014-09-24 | 4,000 | $5.70 | $22.8K | 4,000 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2014-05-20 | 2014-05-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2014-05-07 | 2014-05-08 | 76,068 | — | $0 | 76,068 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2014-05-07 | 2014-05-08 | 12,500 | $8.00 | $100.0K | 15,089 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2013-09-24 | 2013-09-26 | 18,000 | — | $0 | 18,000 | SEC↗ |